Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,234,000 | 7,013,000 | 6,170,000 | 4,880,300 | 4,121,600 |
| Marketable Securities | 1,808,000 | 5,029,000 | 1,800,000 | 1,671,600 | 3,425,100 |
| Receivables | 2,066,000 | 1,921,000 | 1,621,000 | 1,420,900 | 1,166,700 |
| Inventories | 458,000 | 541,000 | 498,000 | 443,400 | 393,100 |
| Other current assets | 501,000 | 388,000 | 779,000 | 984,700 | 606,100 |
| TOTAL | $9,067,000 | $14,892,000 | $10,868,000 | $9,400,900 | $9,712,600 |
| Non-Current Assets | |||||
| PPE Net | 1,367,000 | 1,070,000 | 930,000 | 814,100 | 642,600 |
| Intangibles | 24,216,000 | 13,302,000 | 15,258,000 | 15,737,100 | 6,258,800 |
| Other Non-Current Assets | 830,000 | 877,000 | 1,030,000 | 1,012,300 | 726,100 |
| TOTAL | $26,413,000 | $15,249,000 | $17,218,000 | $17,563,500 | $7,627,500 |
| Total Assets | $35,480,000 | $30,141,000 | $28,086,000 | $26,964,400 | $17,340,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 501,000 | N/A | 501,000 | N/A | 605,900 |
| Accounts payable and accrued liabilities | 418,000 | 305,000 | 247,000 | 240,800 | 198,200 |
| Accrued Expenses | 2,987,000 | 2,523,000 | 2,115,000 | 1,647,700 | 991,100 |
| Other current liabilities | N/A | N/A | N/A | N/A | 275,800 |
| TOTAL | $4,057,000 | $2,987,000 | $2,959,000 | $1,968,900 | $2,112,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,769,000 | 15,838,000 | 13,789,000 | 14,161,400 | 6,265,700 |
| Deferred Revenues | 73,000 | 75,000 | 55,000 | 60,600 | 28,500 |
| Other Non-Current Liabilities | 2,667,000 | 3,034,000 | 2,191,000 | 2,365,900 | 2,409,600 |
| TOTAL | $25,262,000 | $20,233,000 | $18,527,000 | $19,076,500 | $8,703,100 |
| Total Liabilities | $29,319,000 | $23,220,000 | $21,486,000 | $21,045,400 | $10,815,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 702,164 | 752,176 | 777,967 | 781,665 | 800,591 |
| Common Shares | 10,000 | 10,000 | 10,000 | 9,400 | 9,200 |
| Retained earnings | 17,559,000 | 13,061,000 | 10,074,000 | 8,074,400 | 6,472,400 |
| Other shareholders' equity | -50,000 | 287,000 | 419,000 | 767,900 | 915,000 |
| TOTAL | $6,161,000 | $6,921,000 | $6,600,000 | $5,919,000 | $6,524,800 |
| Total Liabilities And Equity | $35,480,000 | $30,141,000 | $28,086,000 | $26,964,400 | $17,340,100 |